Endogenex, Inc.
This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.
This is an observational registry that is designed to facilitate long-term patient follow-up for up to 5 years after an Endogenex procedure. It is structured to enable systematic longitudinal data collection on the safety and long-term clinical outcomes associated with the Endogenex System.
Inclusion Criteria: * Type 2 diabetes * Have been treated with the Endogenex System * Consented to participate in the Endogenex PULSE Registry Exclusion Criteria: * Unwilling or unable to attend study visits * Unwilling or unable to provide medical records to study sites
Verify or correct the compensation shown for this listing.